ABIOMED INC - COMMON STOCK (ABMD)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COMMON STOCK
Total 13F shares
42,991,095
Share change
-1,369,446
Total reported value
$6,241,249,550
Put/Call ratio
193%
Price per share
$145.16
Number of holders
396
Value change
-$230,659,537
Number of buys
182
Number of sells
243

Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q1 2020

As of 31 Mar 2020, ABIOMED INC - COMMON STOCK (ABMD) was held by 396 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,991,095 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, BROWN CAPITAL MANAGEMENT LLC, SANDS CAPITAL MANAGEMENT, LLC, and ALLIANCEBERNSTEIN L.P.. This page lists 396 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.